SEC Form 4 · accession 0001193125-26-259563
Dyne Therapeutics, Inc. · DYN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian S Posner
Director
Period of report
Jun 3, 2026
Accepted (ET)
Jun 5, 2026 · 4:10 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001818794
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 3, 2026 | P | 2,500 | $17.48 | A | 22,500 | D |
Table II — derivative securities
No Table II lines on this filing.